Pulmonary surfactant protein-A (SP-A) restores the surface properties of surfactant after oxidation by a mechanism that requires the Cys6 interchain disulfide bond and the phospholipid binding domain.

Pulmonary surfactant protein-A (SP-A) restores the surface properties of surfactant after oxidation by a mechanism that requires the Cys6 interchain disulfide bond and the phospholipid binding domain.

Item
http://www.wikidata.org/entity/Q44324680
The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung DevelopmentThe pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung developmentRole for phospholipid acyl chains and cholesterol in pulmonary infections and inflammationComparative study of clinical pulmonary surfactants using atomic force microscopyMetal nanoparticle pollutants interfere with pulmonary surfactant function in vitro.Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films. I. Micro- and nanostructures of functional pulmonary surfactant films and the effect of SP-A.Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences.The impact of surfactant protein-A on ozone-induced changes in the mouse bronchoalveolar lavage proteome.Pulmonary surfactant: an immunological perspective.Toll-like receptor 4 senses oxidative stress mediated by the oxidation of phospholipids in extracellular vesicles.Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation.Differential effects of human SP-A1 and SP-A2 variants on phospholipid monolayers containing surfactant protein B.Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C.Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation.The effects of hyperoxia exposure on lung function and pulmonary surfactant in a rat model of acute lung injury.Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin
P2860

Pulmonary surfactant protein-A (SP-A) restores the surface properties of surfactant after oxidation by a mechanism that requires the Cys6 interchain disulfide bond and the phospholipid binding domain.

Item
http://www.wikidata.org/entity/Q44324680
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pulmonary surfactant protein-A ...... e phospholipid binding domain.
@en
Pulmonary surfactant protein-A
@nl
type
label
Pulmonary surfactant protein-A ...... e phospholipid binding domain.
@en
Pulmonary surfactant protein-A
@nl
prefLabel
Pulmonary surfactant protein-A ...... e phospholipid binding domain.
@en
Pulmonary surfactant protein-A
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Pulmonary surfactant protein-A ...... he phospholipid binding domain
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698